Stay updated on Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.

Latest updates to the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page
- Check4 days agoChange DetectedNew history entries on 2026-05-28 and 2026-05-29 add core content for Contacts/Locations and Study Status (including an item labeled 442). The entry dated 2026-05-01 was removed from the history.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new page revision entry (v3.5.4) has been added, replacing the previous revision (v3.5.3). This reflects a software/metadata update to the page rather than content changes.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedTwo new history entries were added on 2026-04-09 and 2026-04-30 (versions 440 and 441) reflecting updates to the Study Status and Contacts/Locations sections, with a subsequent entry on 2026-05-01 referencing these changes. The 2026-03-04 entry was deleted.SummaryDifference0.1%

- Check39 days agoChange DetectedThis updates the displayed ClinicalTrials.gov interface/release version from v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check75 days agoChange DetectedAddition of Revision: v3.5.0 and deletion of Revision: v3.4.3 in the page history.SummaryDifference0.0%

- Check90 days agoChange DetectedThe 2026-03-04 revision (v3.4.3) adds Contacts/Locations and Study Status entries to the record history.SummaryDifference0.1%

Stay in the know with updates to Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.